5-(pentafluorobenzyl)aminosalicylic acid

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name5-(pentafluorobenzyl)aminosalicylic acid
Drug Alias NameNMDA antagonists (Neurotech)neuroprotectants (Neurotech)PBAS
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsHypoxia, BrainBrain Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGnt Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGnt Pharma
Active IndicationsN/A
Inactive IndicationsHypoxia, BrainBrain Injuries

Other Information

ATC CodeN/A
Related LinksN/A